Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Diabetic Macular Edema Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Global Diabetic Macular Edema Treatment Market

 

By Indication Type (Diffuse Diabetic Macular Edema, Focal Diabetic Macular Edema), By Treatment (Laser treatment, Intravitreal Steriods, Anti-angiogenic Drugs Injection, Anti–vascular Endothelial Growth Factor (VEGF) Therapy, Others), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global diabetic macular edema treatment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Diabetic Macular Edema Treatment Market

Diabetic macular edema is a leading cause of vision impairment among people. Macular edema occurs when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling leading to distorted vision. Diabetic macular edema is the disease that is followed by diabetic retinopathy. Diabetic retinopathy is the condition which severely damages the blood vessels of the retina, resulting in vision defects or vision loss. These blood vessels, if left untreated, due to pressure in the eye results in fluid leakage, causing Diabetic Macular Edema (DME).

 

Market Dynamics: Diabetic Macular Edema Treatment Market

Increase in the prevalence of diabetes is the major factor driving growth of global diabetic macular edema treatment market. The prevalence of diabetic macular edema is found to be higher in type 2 diabetes patients than in type 1 diabetes patients. The increased geriatric population and awareness among the patient pool which facilitates early diagnosis to control the disease by proper treatment is driving the market revenue growth. Moreover, advancement in ophthalmic surgery techniques and R&D investment by pharmaceutical companies are adding fuel to the growth of global diabetic macular edema treatment market. However, factors such as lack of skilled ophthalmologists, and extended approval time for drugs are hampering the global diabetic macular edema treatment market.

 

Market Scope: Diabetic Macular Edema Treatment Market

Diabetic macular edema treatment market is segmented based on the indication, treatment, and distribution channel

Based on the indication type, the market is segmented into the following:

  • Diffuse Diabetic Macular Edema
  • Focal Diabetic Macular Edema

Based on the treatment, the market is segmented into the following:

  • Laser Treatment
    • Scatter Laser
    • Grid pattern photocoagulation
    • Focal Laser
  • Intravitreal Steroids
    • Ozurdex
    • Lluvien
    • Kenalog
  • Anti-angiogenic Drugs Injection
    • Eylea
    • Avastin
    • Lucentis
  • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

 

Regional Analysis:  Diabetic Macular Edema Treatment Market

Geographically, global diabetic macular edema treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia-Pacific diabetic macular edema treatment market is growth is driven by increases in the prevalence of diabetes. Availability large patient pool in Asia-Pacific region expected to drive the market revenue growth significantly in the aforesaid region.

 

Competition Assessment: Diabetic Macular Edema Treatment Market

Some of the players in the global diabetic macular edema treatment market include:

  • Eyetech Pharmaceuticals (U.S)
  • Alimera Sciences (U.S)
  • Archemix (U.S)
  • Genentech Inc. (U.S)
  • Novartis Europharm Limited (Novartis AG) (India)
  • Stiefel Laboratories Inc., (GlaxoSmithKline Plc.) (U.S)
  • Allergan, Inc. (Ireland)
  • IRIDEX Corporation (U.S)
  • Bausch and Lomb Incorporated (U.S)

 

Notable Market Developments: Diabetic Macular Edema Treatment Market

  • In May 2017, Archemix announced a milestone achievement by collaborating Eyetech as a part of its board to discover and develop therapeutic aptamers for ophthalmology

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  1. Executive Summary
  2. Global Diabetic Macular Edema Treatment Market Introduction
    • Global Diabetic Macular Edema Treatment Market – Taxonomy
    • Global Diabetic Macular Edema Treatment Market –Definitions
      • Indication Type
      • Treatment
      • End User
  1. Global Diabetic Macular Edema Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Diabetic Macular Edema Treatment Market Dynamic Factors – Impact Analysis
    • Global Diabetic Macular Edema Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Diabetic Macular Edema Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Diabetic Macular Edema Treatment Market, By Indication Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Diffuse Diabetic Macular Edema
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Focal Diabetic Macular Edema
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Diabetic Macular Edema Treatment Market Forecast, By Treatment,2013 – 2017 and Forecast, 2018 – 2024
    • Laser Treatment
      • Scatter Laser
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Grid pattern photocoagulation
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Focal Laser
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Intravitreal Steroids
        • Ozurdex
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Lluvien
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Kenalog
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Anti-angiogenic Drugs Injection
          • Eylea
            • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Avastin
            • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Lucentis
            • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
            • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Others
            • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
  1. Global Diabetic Macular Edema Treatment Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ophthalmic Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Surgical Centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Diabetic Macular Edema Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Region, 2018 – 2024
  2. North America Diabetic Macular Edema Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Indication Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2018 – 2024
    • North America Diabetic Macular Edema Treatment Market Dynamics – Trends
  3. Europe Diabetic Macular Edema Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Indication Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2018 – 2024
    • Europe Diabetic Macular Edema Treatment Market Dynamics – Trends
  4. Asia-Pacific Diabetic Macular Edema Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Indication Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2018 – 2024
    • Asia-Pacific Diabetic Macular Edema Treatment Market Dynamics – Trends
  5. Latin America Diabetic Macular Edema Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Indication Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2018 – 2024
    • Latin America Diabetic Macular Edema Treatment Market Dynamics – Trends
  6. Middle East and Africa Diabetic Macular Edema Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Indication Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2018 – 2024
    • MEA Diabetic Macular Edema Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Indication Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Eyetech Pharmaceuticals (U.S)
      • Alimera Sciences (U.S)
      • Archemix (U.S)
      • Genentech Inc. (U.S)
      • Novartis Europharm Limited (Novartis AG) (India)
      • Stiefel Laboratories Inc., (GlaxoSmithKline Plc.) (U.S)
      • Allergan, Inc. (Ireland)
      • IRIDEX Corporation (U.S)
      • Bausch and Lomb Incorporated (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

 

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553